| |
| |
|
| Insider
Information: |
Wan Mark A |
| Relationship: |
Former 10% Beneficial ... |
| City: |
Portola Valley |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
2,418 |
|
|
Indirect Shares
|
7,558,367 |
|
|
| Direct
Value |
$2,466 |
|
|
|
Indirect Value
|
$7,378,277 |
|
|
| Total
Shares |
7,560,785 |
|
|
| Total
Value |
$7,380,743 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Solta Medical Inc |
SLTM |
10% Owner |
|
0 |
2008-12-23 |
6,582,733 |
Premium* |
|
|
Epocrates Inc |
EPOC |
Director |
2011-02-07 |
0 |
2013-03-12 |
0 |
Premium* |
|
|
Concert Pharmaceuticals, Inc. |
CNCE |
10% Owner |
|
0 |
2014-02-19 |
801,726 |
Premium* |
|
|
Acelrx Pharmaceuticals Inc |
ACRX |
Director |
2023-10-10 |
2,418 |
2014-03-10 |
126,153 |
Premium* |
|
|
Nevro Corp |
NVRO |
Former 10% Beneficial ... |
|
0 |
2014-11-12 |
47,755 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2023-10-10 |
4 |
A |
$0.00 |
$0 |
D/D |
581 |
2,418 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2022-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,500 |
36,750 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
21,250 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
11,250 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2019-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
3,750 |
0 |
- |
|
| NVRO |
Nevro Corp |
Former 10% Beneficial Owner |
– – – |
2014-11-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,206,403 |
47,755 |
0 |
- |
|
| NVRO |
Nevro Corp |
10% Owner |
– – • |
2014-11-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,166 |
|
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • • |
2014-03-10 |
4 |
S |
$12.36 |
$10,324,642 |
I/I |
(835,327) |
126,153 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • • |
2014-03-07 |
4 |
S |
$11.96 |
$2,025,400 |
I/I |
(164,673) |
137,403 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
10% Owner |
– – • |
2014-02-19 |
4 |
B |
$14.00 |
$1,449,000 |
I/I |
103,500 |
801,726 |
1.5 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
10% Owner |
– – • |
2014-02-19 |
4 |
A |
$0.00 |
$0 |
I/I |
690,264 |
700,462 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
10% Owner |
– – • |
2014-02-19 |
4 |
B |
$14.00 |
$1,449,000 |
I/I |
103,500 |
777,620 |
1.5 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
10% Owner |
– – • |
2014-02-19 |
4 |
A |
$0.00 |
$0 |
I/I |
690,264 |
679,401 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
10% Owner |
– – • |
2014-02-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
25,663 |
|
- |
|
| EPOC |
Epocrates Inc |
Director |
– • – |
2013-03-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,655,329) |
0 |
0 |
- |
|
| EPOC |
Epocrates Inc |
Former 10% Owner |
– • – |
2011-02-07 |
4 |
S |
$16.00 |
$4,673,856 |
I/I |
(292,116) |
1,655,329 |
0 |
- |
|
| EPOC |
Epocrates Inc |
Former 10% Owner |
– • – |
2011-02-07 |
4 |
A |
$0.00 |
$0 |
I/I |
1,947,445 |
1,947,445 |
0 |
- |
|
| SLTM |
Solta Medical Inc |
10% Owner |
– – • |
2008-12-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,582,733 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
